Corrigendum to “Single-chain fragment variable antibody targeting cholecystokinin-B receptor for pain reduction” [Neurobiol. Pain 10 (2021) 100067]
K.N. Westlund,
M.A. Montera,
A.E. Goins,
S.R.A. Alles,
M. Afaghpour-Becklund,
R. Bartel,
R. Durvasula,
A. Kunamneni
Affiliations
K.N. Westlund
Department of Anesthesiology & Critical Care Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87106-0001, USA; Biomedical Laboratory Research & Development (121F), New Mexico VA Health Care System, Albuquerque, NM, USA; Corresponding author.
M.A. Montera
Department of Anesthesiology & Critical Care Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87106-0001, USA
A.E. Goins
Department of Anesthesiology & Critical Care Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87106-0001, USA
S.R.A. Alles
Department of Anesthesiology & Critical Care Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87106-0001, USA
M. Afaghpour-Becklund
Department of Anesthesiology & Critical Care Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87106-0001, USA
R. Bartel
Department of Anesthesiology & Critical Care Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87106-0001, USA
R. Durvasula
Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic, Jacksonville, FL, USA; Department of Medicine, Loyola University Medical Center, Maywood, IL 60153-3328, USA
A. Kunamneni
Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic, Jacksonville, FL, USA; Department of Medicine, Loyola University Medical Center, Maywood, IL 60153-3328, USA
